| Merck KGaA | 102.50 / -0.29% |
| Date/Time | 12/13 / 17:29 |
| Chg. / Chg.(%) | -0.30 / -0.29% |
| Bid | 102.05 / 175 |
| Ask | 104.70 / 173 |
| Open | 103.50 |
| Previous Close | 102.80 |
| High | 103.75 |
| Low | 102.10 |
| Volume [EUR] | 7,297,112.73 |
| Volume [Units] | 70,945 |
| Price fixings | 1205 |
| ISIN | DE0006599905 |
| Security | MRK/D |
| Exchange | Cboe Europe BXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 102.500 | ||
| Xetra | 102.70 |  |
543,621 |
| Cboe Europe .. | 102.50 | |
179,725 |
| London Inter.. | 102.40 | |
126,146 |
| Turquoise | 102.50 | |
81,074 |
| Cboe Europe .. | 102.50 | |
70,945 |
| Stuttgart | 102.600 | |
4,330 |
| TradeGate | 103.100 | |
3,978 |
| München | 103.00 | |
950 |
| Hamburg | 102.65 | |
520 |
| Borsa Italia.. | 103.30 | |
200 |
| Frankfurt | 104.4000 |  |
150 |
| Vienna Globa.. | 102.60 | |
0 |
| Düsseldorf | 102.50 | |
0 |
| Hannover | 104.30 | |
0 |
| Berlin | 104.15 | |
0 |
| SIX Swiss Ex.. | 102.20 | |
|
| SIX Swiss Ex.. | 97.00 | |
|
| gettex | 102.750 | |
|
| Nasdaq Other.. | 112.3400 | 146 | |
| EUREX | Options | ||
News
- Merck to acquire ArQule for $2.7B
12/09/2019 / 23:36 - TeleTrader - Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 14:00 - GlobeNewswire - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11/09/2019 / 14:02 - GlobeNewswire - Merck says Q3 sales jump 12% YoY to $12.4B
10/29/2019 / 11:49 - TeleTrader - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer in Podium and Poster Presentations at the Fifth International Cancer lmmunotherapy Conference in Paris, France
09/27/2019 / 12:05 - GlobeNewswire
Real-time